Literature DB >> 7548537

Enterotoxigenic Bacteroides fragilis.

C L Sears1, L L Myers, A Lazenby, R L Van Tassell.   

Abstract

Enterotoxigenic Bacteroides fragilis (ETBF) has been recently associated with watery diarrheal disease in livestock and young children. These strains of B. fragilis secrete an extracellular heat-labile protein toxin with a mess of approximately 20 kD. This toxin has been shown to have two major biological activities: stimulation of secretion in ligated intestinal segments in lambs and calves and alteration of the morphology of intestinal epithelial cell lines in vitro. In vivo the pathology of animal intestine exposed to an ETBF strain is disruption of the colonic epithelium with rounded, swollen surface epithelial cells. Similarly, in vitro intestinal epithelial cells derived from human colonic carcinomas become rounded and detach from neighboring cells after treatment with the ETBF toxin. These results suggest that the ETBF toxin is a secretory cytoskeleton-altering toxin. However, the contribution of the ETBF toxin to the pathogenesis of ETBF-associated diarrheal disease remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7548537     DOI: 10.1093/clinids/20.supplement_2.s142

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  30 in total

1.  Prevalence of fragilysin gene in Bacteroides fragilis isolates from blood and other extraintestinal samples.

Authors:  Ina Foulon; Denis Piérard; Gaëtan Muyldermans; Kristof Vandoorslaer; Oriane Soetens; Paul Rosseel; Sabine Lauwers
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

2.  Mutation of the zinc-binding metalloprotease motif affects Bacteroides fragilis toxin activity but does not affect propeptide processing.

Authors:  Augusto A Franco; Simy L Buckwold; Jai W Shin; Miguel Ascon; Cynthia L Sears
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

3.  The C-terminal region of Bacteroides fragilis toxin is essential to its biological activity.

Authors:  Cynthia L Sears; Simy L Buckwold; Jai W Shin; Augusto A Franco
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

4.  Identification of a third metalloprotease toxin gene in extraintestinal isolates of Bacteroides fragilis.

Authors:  G T Chung; A A Franco; S Wu; G E Rhie; R Cheng; H B Oh; C L Sears
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 5.  Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion.

Authors:  C L Sears; J B Kaper
Journal:  Microbiol Rev       Date:  1996-03

6.  Cloning and characterization of the Bacteroides fragilis metalloprotease toxin gene.

Authors:  A A Franco; L M Mundy; M Trucksis; S Wu; J B Kaper; C L Sears
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

7.  Meningitis due to enterotoxigenic Bacteroides fragilis.

Authors:  P Aucher; J P Saunier; G Grollier; M Sebald; J L Fauchère
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-10       Impact factor: 3.267

Review 8.  Microbiota in cancer development and treatment.

Authors:  Muhammad Hassan Raza; Kamni Gul; Abida Arshad; Naveeda Riaz; Usman Waheed; Abdul Rauf; Fahad Aldakheel; Shatha Alduraywish; Maqbool Ur Rehman; Muhammad Abdullah; Muhammad Arshad
Journal:  J Cancer Res Clin Oncol       Date:  2018-12-12       Impact factor: 4.553

9.  Identification and characterization of conjugative transposons CTn86 and CTn9343 in Bacteroides fragilis strains.

Authors:  Simy L Buckwold; Nadja B Shoemaker; Cynthia L Sears; Augusto A Franco
Journal:  Appl Environ Microbiol       Date:  2006-10-27       Impact factor: 4.792

10.  Bacteroides fragilis enterotoxin induces intestinal epithelial cell secretion of interleukin-8 through mitogen-activated protein kinases and a tyrosine kinase-regulated nuclear factor-kappaB pathway.

Authors:  Shaoguang Wu; Jan Powell; Nes Mathioudakis; Sheryl Kane; Ellen Fernandez; Cynthia L Sears
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.